Evidence map›Paper›PMID 37792545›Full record

ArticleBiomacromolecules2023

Poly(2-oxazoline)/saRNA Polyplexes for Targeted and Nonviral Gene Delivery.

Graham Hayes, Beatriz Dias-Barbieri, Gokhan Yilmaz, Robin J Shattock, C Remzi Becer

Abstract read
In one paragraph

Article in Biomacromolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Graham HayesDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, United Kingdom.
Beatriz Dias-BarbieriDepartment of Infectious Diseases, Imperial College London, Norfolk Place, London W21PG, United Kingdom.
Gokhan YilmazDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, United Kingdom.
Robin J ShattockDepartment of Infectious Diseases, Imperial College London, Norfolk Place, London W21PG, United Kingdom.
C Remzi BecerDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, United Kingdom.ORCID 0000-0003-0968-6662

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA delivery has been demonstrated to be a potent method of vaccine delivery, as demonstrated by the recent success of the COVID-19 vaccines. Polymers have been shown to be effective vehicles for RNA delivery, with poly(ethylene imine) (PEI) being the current gold standard for delivery. Nonetheless, PEI has toxicity concerns, and so finding alternatives is desirable. Poly(2-oxazoline)s are a promising alternative to PEI, as they are generally biocompatible and offer a high degree of control over the polymer structure. Here, we have synthesized an ionizable primary amine 2-oxazoline and combined it with a double bond containing oxazoline to synthesize a small library of charged statistical and block copolymers. The pendant double bonds were reacted further to decorate the polymers with glucose via a thiol-ene click reaction. All polymers were shown to have excellent cell viability, and the synthesized block polymers showed promising complexation efficiencies for the saRNA, demonstrating a clear structure-property relationship. The polymer transfection potential was tested in various cell lines, and a polymer composition with an amine/glucose ratio of 9:27 has demonstrated the best transfection potential across all cell lines tested. Overall, the results suggest that block polymers with a cationic segment and high levels of glycosylation have the best complexation efficiency and RNA expression levels.

Indexed as

COVID-19 VaccinesPolymersAminesGlucoseHumansOxazolesRNAAminesCOVID-19 VaccinesGlucoseOxazolespoly(2-oxazoline)PolymersRNA

Identifiers

PMID37792545
PMCPMC10646937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.